Want to see CH:DAE full AI Analyst Report?
DAE Stock Chart & Stats
CHF138.00
-CHF3.60(-2.61%)
At close: 4:00 PM EDT
CHF138.00
-CHF3.60(-2.61%)
Day’s Range― - ―
52-Week RangeCHF131.80 - CHF171.60
Previous CloseN/A
Volume6.48K
Average Volume (3M)12.37K
Market Cap
CHF2.33B
Enterprise ValueCHF3.08K
Total Cash (Recent Filing)CHF83.60M
Total Debt (Recent Filing)CHF507.50M
Price to Earnings (P/E)28.2
Beta0.61
Next Earnings
Feb 11, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.35%
Share Statistics
EPS (TTM)4.83
Shares Outstanding12,600,000
10 Day Avg. Volume11,336
30 Day Avg. Volume12,370
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)7.53
Price to Sales (P/S)2.53
P/FCF Ratio21.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF169.00Price Target Upside22.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)5.79
Revenue Forecast (FY)CHF1.17B
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent positive free cash flow across multiple years provides durable internal funding for capex, working capital and debt reduction. This persistent cash generation supports strategic flexibility, reduces reliance on external financing and underpins long‑term solvency and reinvestment ability.
Regulated Healthcare End-marketsServing regulated pharma and healthcare markets creates high switching costs and repeat demand due to long qualification cycles. This regulatory stickiness and technical manufacturing expertise form a structural competitive advantage supporting recurring B2B revenue and higher customer retention.
2025 Revenue ReboundA material top‑line rebound signals regained end‑market demand and the firm's ability to capture orders. If sustained, higher volumes improve operating leverage, help absorb fixed costs and can materially strengthen margins and earnings power over the medium term.
Bears Say
Elevated LeverageSignificantly higher leverage compared with historical levels reduces financial flexibility and increases sensitivity to demand shocks or rate moves. Even with some 2025 debt reduction, the elevated capital structure constrains strategic investments and heightens refinancing and solvency risk.
Profitability VolatilityMaterial margin and earnings swings weaken earnings predictability and suggest structural pressure in cost, mix or pricing. Persistent volatility hampers long‑term planning, undermines sustainable cash conversion and makes delivery on strategic goals less reliable.
Choppy Free Cash Flow GrowthVariability in free cash flow, driven by working capital swings and uneven growth, limits reliable internal funding for debt paydown and reinvestment. This structural cash volatility raises execution risk and reduces the consistency of balance‑sheet repair efforts.
Daetwyler Holding News
DAE FAQ
What was Daetwyler Holding’s price range in the past 12 months?
Daetwyler Holding lowest stock price was CHF131.80 and its highest was CHF171.60 in the past 12 months.
What is Daetwyler Holding’s market cap?
Daetwyler Holding’s market cap is CHF2.33B.
When is Daetwyler Holding’s upcoming earnings report date?
Daetwyler Holding’s upcoming earnings report date is Feb 11, 2027 which is in 182 days.
How were Daetwyler Holding’s earnings last quarter?
Daetwyler Holding released its earnings results on Jul 23, 2026. The company reported CHF2.312 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Daetwyler Holding overvalued?
According to Wall Street analysts Daetwyler Holding’s price is currently Undervalued.
Does Daetwyler Holding pay dividends?
Daetwyler Holding pays a Annually dividend of CHF3.2 which represents an annual dividend yield of 2.35%. See more information on Daetwyler Holding dividends here
What is Daetwyler Holding’s EPS estimate?
Daetwyler Holding’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daetwyler Holding have?
Daetwyler Holding has 12,600,000 shares outstanding.
What happened to Daetwyler Holding’s price movement after its last earnings report?
Daetwyler Holding reported an EPS of CHF2.312 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.86%.
Which hedge fund is a major shareholder of Daetwyler Holding?
Currently, no hedge funds are holding shares in CH:DAE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Daetwyler Holding
Dätwyler Holding AG, established in 1915 and headquartered in Altdorf, Switzerland, operates as a subsidiary of Pema Holding AG. The company specializes in the global manufacturing and distribution of elastomer components for a variety of sectors, including healthcare, mobility, oil and gas, and food and beverage, with its reach extending across Europe, North America, South America, and Asia. Dätwyler is organized into two core divisions: Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment provides critical rubber components for medical applications such as prefilled syringes, injection pens, vial closures for injectable pharmaceuticals, blood collection systems, IV administration sets, disposable syringes, and diagnostic and medical devices. Meanwhile, the Industrial Solutions segment offers a diverse portfolio of products, including electromobility solutions, active assistance and safety systems, brake components, fuel and engine management systems, exhaust gas aftertreatment, and sealing components for upstream systems, power tools, and the water and process industries.
DAE Stock 12 Month Forecast
Average Price Target
CHF169.00
▲(22.46% Upside)
Technical Analysis
dormakaba Holding AG
―
Kardex AG
―
Interroll Holding AG
―
Bossard Holding AG
―
Montana Aerospace AG
―

